You have 9 free searches left this month | for more free features.

Vorolanib

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Thymic Carcinoma, NSCLC, Refractory Thoracic Tumors Trial in United States (VEGFR/PDGFR Dual Kinase Inhibitor X-82, Nivolumab)

Active, not recruiting
  • Thymic Carcinoma
  • +3 more
  • VEGFR/PDGFR Dual Kinase Inhibitor X-82
  • Nivolumab
  • Palo Alto, California
  • +6 more
Sep 21, 2022

Solid Tumor, Hepatocellular Carcinoma, Gastric Cancer Trial in Saint Louis (Vorolanib, Nivolumab, Pembrolizumab)

Terminated
  • Solid Tumor
  • +3 more
  • Vorolanib
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 27, 2020

Advanced Malignant Solid Tumors Trial in Shanghai (CM082)

Active, not recruiting
  • Advanced Malignant Solid Tumors
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Nov 10, 2022

Advanced Solid Tumor Trial in Nanjing ([14]CM082 suspension)

Active, not recruiting
  • Advanced Solid Tumor
  • [14]CM082 suspension
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital Affiliated to Nanjing Madical Universi
Nov 24, 2021

Advanced Malignant Solid Tumors Trial in Hangzhou (CM082 tablet (test product), CM082 tablet (reference product))

Completed
  • Advanced Malignant Solid Tumors
  • CM082 tablet (test product)
  • CM082 tablet (reference product)
  • Hangzhou, Zhejiang, China
    The 1st Phase Clinical Research Center of the Second Affiliated
Nov 24, 2021

Renal Cell Cancer Metastatic Trial in Beijing (CM082 combined with everolimus, CM082, Everolimus)

Unknown status
  • Renal Cell Cancer Metastatic
  • CM082 combined with everolimus
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Feb 4, 2021

Myopic Choroidal Neovascularisation Trial in Beijing (CM082)

Suspended
  • Myopic Choroidal Neovascularisation
  • Beijing, China
    Peking Union Medical College Hospital
Mar 7, 2021

Advanced Malignant Solid Tumors Trial in Hangzhou (CM082 with fed or fasting)

Completed
  • Advanced Malignant Solid Tumors
  • CM082 with fed or fasting
  • Hangzhou, Zhejiang, China
    The 1st Phase Clinical Research Center of the Second Affiliated
May 20, 2020

Age-Related Macular Degeneration Trial in China (CM082 tablet)

Suspended
  • Age-Related Macular Degeneration
  • CM082 tablet
  • Beijing, Beijing, China
  • +5 more
Jan 8, 2020

Age-Related Macular Degeneration Trial in Wuhan (CM082)

Unknown status
  • Age-Related Macular Degeneration
  • Wuhan, Hubei, China
    Renmin Hospital of Wuhan University, Hubei General Hospital
Jan 8, 2020

Advanced Cancer Trial in Beijing, Tianjin (CM082 Tablet)

Completed
  • Advanced Cancer
  • CM082 Tablet
  • Beijing, Beijing, China
  • +2 more
Jul 2, 2019